News | June 14, 2024
Suven to acquire a majority stake in CDMO player ‘Sapala Organics’
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Merck shared updates on the company’s oncology pipeline and focused R&D approach
225Ac-PSMA-Trillium is an investigational next-generation PSMA-targeted alpha therapy with potential to treat patients with advanced metastatic prostate cancer
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
Aurigene.AI is an end-to-end solution for small molecule drug discovery
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Additional capacity broadens Grace’s fine chemical capabilities for API production
BHL will undertake the development and supply of these molecules
Argo will receive upfront payments of US$ 185 million from Novartis and is eligible to receive potential option and milestone payments as well as tiered royalties on commercial sales.
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
